Disparition de kératoses actiniques avec la capécitabine = Resolution of actinic keratosis with capecetabinSCHMUTZ, J.-L; TRECHOT, P.Annales de dermatologie et de vénéréologie. 2012, Vol 139, Num 11, pp 759-760, issn 0151-9638, 2 p.Article

Comparative pharmacology of oral fluoropyrimidines: a focus on pharmacokinetics, pharmacodynamics and pharmacomodulationMILANO, G; FERRERO, J.-M; FRANCOIS, E et al.British journal of cancer. 2004, Vol 91, Num 4, pp 613-617, issn 0007-0920, 5 p.Article

Capecitabine- induced multifocal leukoencephalopathy : A report of five casesVIDENOVIC, A; SEMENOV, I; RAIZER, J. J et al.Neurology. 2005, Vol 65, Num 11, pp 1792-1794, issn 0028-3878, 3 p.Article

Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancerSOUGLAKOS, John; ANDROULAKIS, Nikolaos; GEORGOULIAS, Vassilios et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 5, pp 1284-1287, issn 0360-3016, 4 p.Article

Genital Erythrodysesthesia as a Severe Manifestation of Capecitabine Therapy: A Report of 3 CasesFLETA-ASIN, Beatriz; ALCANTARA-GONZALEZ, Javier; ALONSO-CASTRO, Leticia et al.Archives of dermatology (1960). 2011, Vol 147, Num 9, pp 1123-1124, issn 0003-987X, 2 p.Article

Resolving actinic keratoses: an expected side-effect of capecitabine therapyAL-NIAIMI, F; LYON, C.Clinical and experimental dermatology (Print). 2012, Vol 37, Num 1, pp 68-69, issn 0307-6938, 2 p.Article

Capecitabine-Induced Chest Pain Relieved by DiltiazemAMBROSY, Andrew P; KUNZ, Pamela L; FISHER, George A et al.The American journal of cardiology. 2012, Vol 110, Num 11, pp 1623-1626, issn 0002-9149, 4 p.Article

Capecitabine-induced coronary vasospasm: A case reportRIZVI, Asad A; SCHAUER, Peter; OWLIA, Dariush et al.Angiology. 2004, Vol 55, Num 1, pp 93-97, issn 0003-3197, 5 p.Article

Optimizing Chemotherapy Dose and Schedule by Norton-Simon Mathematical ModelingTRAINA, Tiffany A; DUGAN, Ute; HIGGINS, Brian et al.Breast disease. 2010, Vol 31, Num 1, pp 7-18, issn 0888-6008, 12 p.Article

Hiperpigmentación secundaria a capecitabina = Capecitabine induced hyperpigmentationVAZQUEZ-BAYO, C; RODRIGUEZ-BUJALDON, A. L; JIMENEZ-PUYA, R et al.Actas dermo-sifiliográficas (Ed. impresa). 2007, Vol 98, Num 7, pp 491-493, issn 0001-7310, 3 p.Article

The frequency and severity of capecitabine-induced hypertriglyceridaemia in routine clinical practice: a prospective studyMICHIE, C. O; SAKALA, M; RIVANS, I et al.British journal of cancer. 2010, Vol 103, Num 5, pp 617-621, issn 0007-0920, 5 p.Article

Pharmacokinetic and pharmacodynamic comparison of fluoropyrimidine derivatives, capecitabine and 5'-deoxy-5-fluorouridine (5'-DFUR)EBI, Hiromichi; SIGEOKA, Yasushi; SAEKI, Toshiaki et al.Cancer chemotherapy and pharmacology. 2005, Vol 56, Num 2, pp 205-211, issn 0344-5704, 7 p.Article

Solubility of capecitabine and docetaxel in supercritical carbon dioxide: Data and the best correlationYAMINI, Yadollah; HOJJATI, Mohammad; KALANTARIAN, Pardis et al.Thermochimica acta. 2012, Vol 549, pp 95-101, issn 0040-6031, 7 p.Article

Synthesis and biological activity evaluation of cytidine-5'-deoxy-5-fluoro-N-[(alkoxy/aryloxy)] carbonyl-cyclic 2',3'-carbonatesJHANSI RANI, V; RAGHAVENDRA, A; KISHORE, P et al.European journal of medicinal chemistry. 2012, Vol 54, pp 690-696, issn 0223-5234, 7 p.Article

Stability studies of capecitabineLASZCZ, M; TRZCINSKA, K; FILIP, K et al.Journal of thermal analysis and calorimetry. 2011, Vol 105, Num 3, pp 1015-1021, issn 1388-6150, 7 p.Article

Weekday on-weekend off oral capecitabine : a phase I study of a continuous schedule better simulating protracted fluoropyrimidine therapyPENTHEROUDAKIS, G; PAPPAS, P; MARSELOS, M et al.Cancer chemotherapy and pharmacology. 2007, Vol 60, Num 5, pp 733-739, issn 0344-5704, 7 p.Article

Capecitabine-induced severe hypertriglyceridemia : Report of two casesKURT, Mevlut; BABAOGLU, Melih O; YASAR, Umit et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 2, pp 328-331, issn 1060-0280, 4 p.Article

Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-1 trialHOFHEINZ, R.-D; HARTMANN, J. T; HOCHHAUS, A et al.British journal of cancer. 2004, Vol 91, Num 5, pp 834-838, issn 0007-0920, 5 p.Article

Identification of Novel Germline Polymorphisms Governing Capecitabine SensitivityO'DONNELL, Peter H; STARK, Amy L; GAMAZON, Eric R et al.Cancer. 2012, Vol 118, Num 16, pp 4063-4073, issn 0008-543X, 11 p.Article

Apport de la capécitabine dans le carcinome hépatocellulaire (CHC) inopérable en Côte d'Ivoire = Contribution of capecitabine in patients with unresectable hepatocellular carcinoma in Ivory CoastTOURE, M; ADOUBI, I; COULIBALY, J. Didi-Kouko et al.Médecine d'Afrique noire. 2012, Vol 59, Num 11, pp 523-528, issn 0465-4668, 6 p.Article

Toxic death-case after capecitabine + oxaliplatin (XELOX) administration : probable implication of dihydropyrimidine deshydrogenase deficiencyCICCOLINI, Joseph; MERCIER, Cedric; LACARELLE, Bruno et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 2, pp 272-275, issn 0344-5704, 4 p.Article

Successful Treatment of HER-2-Positive Metastatic Apocrine Carcinoma of the Skin with Lapatinib and CapecitabineHIDAKA, Takanori; FUJIMURA, Taku; WATABE, Akiko et al.Acta dermato-venereologica. 2012, Vol 92, Num 6, pp 654-655, issn 0001-5555, 2 p.Article

Complete Response of Metastatic Malignant Hidradenocarcinoma to Capecitabine TreatmentLERNER, Adam; BECKFORD, Angela; UGENT, Steve et al.Archives of dermatology (1960). 2011, Vol 147, Num 8, pp 998-999, issn 0003-987X, 2 p.Article

Exudative, Nonhealing Scalp: A Complication of Systemic Chemotherapy With Capecitabine and BevacizumabBLACK, Jeanette M; HODARI, Kafele T; ROGERS, Nicole et al.Archives of dermatology (1960). 2011, Vol 147, Num 1, pp 134-135, issn 0003-987X, 2 p.Article

A Dynamic Model of Hand-and-Foot Syndrome in Patients Receiving CapecitabineHENIN, E; YOU, B; TOD, M et al.Clinical pharmacology and therapeutics. 2009, Vol 85, Num 4, pp 418-425, issn 0009-9236, 8 p.Article